secretin synthetic porcine
SECREFLO (secretin synthetic porcine) is mechanism of action 12. First approved in 2002.
Drug data last refreshed 20h ago · AI intelligence enriched 2mo ago
SECREFLO is a synthetic porcine secretin administered intravenously as a solution for reconstitution. Secretin is a gastrointestinal hormone used diagnostically to stimulate pancreatic secretion and assess pancreatic function. The drug works by mimicking natural secretin to provoke measurable pancreatic responses in clinical testing.
With LOE approaching on a niche diagnostic product with low competitive pressure (30%), the commercial team is likely consolidating, emphasizing market retention over growth.
Mechanism of Action 12.1 Mechanism of Action The primary action of ChiRhoStim is to stimulate pancreatic ductal cells to secrete pancreas fluid in large volumes that contain bicarbonate. Secretin is a hormone that is normally released from the duodenum upon exposure of the proximal intestinal lumen…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
SECREFLO offers limited career growth opportunities given its niche market, mature lifecycle, and minimal linked job openings (0). Roles on this product are typically focused on sustaining existing sales and managing prescriber relationships in gastroenterology rather than driving innovation.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.